Rocuronium versus succinylcholine: are they equally effective during rapid-sequence induction of anesthesia?

Area of Science:

• Anesthesiology
• Pharmacology
• Pediatric Critical Care

Background:

• Rapid-sequence induction (RSI) is critical for emergency airway management in children.
• Succinylcholine has been the standard neuromuscular blocking agent for RSI due to its rapid onset and short duration.
• Alternative agents are sought to optimize RSI conditions and patient safety.

Purpose of the Study:

• To compare the onset and quality of muscle paralysis and intubation conditions between succinylcholine and rocuronium during RSI in pediatric patients.
• To evaluate rocuronium as a potential substitute for succinylcholine in this setting.

Main Methods:

• A randomized study involving pediatric patients undergoing emergency surgery.
• Patients received either thiopental with succinylcholine (1.5 mg/kg) or thiopental with rocuronium (1.2 mg/kg).
• Intubating conditions, onset of apnea, and neuromuscular recovery were assessed by blinded anesthesiologists and train-of-four monitoring.

Main Results:

• No significant difference was observed in excellent or good/excellent intubating scores between the rocuronium and succinylcholine groups.
• The time to onset of apnea was similar for both agents.
• Significantly faster recovery of neuromuscular function (return of first twitch) was noted with succinylcholine compared to rocuronium.

Conclusions:

• Rocuronium (1.2 mg/kg) with thiopental provides intubating conditions comparable to succinylcholine (1.5 mg/kg) with thiopental in pediatric emergency RSI.
• Rocuronium is a viable alternative to succinylcholine for pediatric RSI when rapid reversal of neuromuscular blockade is not a primary concern.